
FDA Takes Multiple Actions to Expand Use of Pfizer-BioNTech COVID-19 Vaccine
The U.S. Food and Drug Administration amended the emergency use authorization (EUA) for the Pfizer-BioNTech COVID-19 Vaccine to: Expand the use of a single booster dose to include use in individuals 12 through 15 years of age. Shorten the time … Continue reading FDA Takes Multiple Actions to Expand Use of Pfizer-BioNTech COVID-19 Vaccine